Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial Evaluating the Activity of Abiraterone Acetate Plus Prednisone in Patients With a Molecular Apocrine HER2-negative Locally Advanced or Metastatic Breast Cancer

NCT01842321 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT01842321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01842321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial Evaluating the Activity of Abiraterone Acetate Plus Prednisone in Patients With a Molecular Apocrine HER2-negative Locally Advanced or Metastatic Breast Cancer
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2013
Completion date
July 4, 2018
Enrollment
34 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer